Page last updated: 2024-09-03

imatinib mesylate and Neurofibroma

imatinib mesylate has been researched along with Neurofibroma in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (50.00)29.6817
2010's1 (25.00)24.3611
2020's1 (25.00)2.80

Authors

AuthorsStudies
Chhabra, G; Verma, P1
Burns, D; Chen, S; Clapp, DW; Horn, W; Hutchins, G; Ingram, DA; Knowles, S; Li, X; Li, Y; Parada, LF; Robertson, K; Vakili, ST; Yang, FC; Yang, X; Yang, Y; Yu, M; Yuan, J; Zhang, S; Zhu, Y1
Clapp, DW; Staser, K; Yang, FC1
Burgin, S; Chen, S; Clapp, DW; Clegg, T; Estwick, SA; Ingram, DA; Khalaf, W; Li, X; Morgan, T; Parada, LF; Travers, J; Yang, FC; Yuan, J1

Reviews

1 review(s) available for imatinib mesylate and Neurofibroma

ArticleYear
Mast cells and the neurofibroma microenvironment.
    Blood, 2010, Jul-15, Volume: 116, Issue:2

    Topics: Animals; Antineoplastic Agents; Benzamides; Child, Preschool; Female; Humans; Imatinib Mesylate; Mast Cells; Neurofibroma; Neurofibromatosis 1; Piperazines; Pyrimidines

2010

Other Studies

3 other study(ies) available for imatinib mesylate and Neurofibroma

ArticleYear
Successful treatment of cutaneous (dermal) neurofibromas with imatinib mesylate.
    Dermatologic therapy, 2020, Volume: 33, Issue:2

    Topics: Antineoplastic Agents; Benzamides; Humans; Imatinib Mesylate; Neurofibroma; Piperazines

2020
Nf1-dependent tumors require a microenvironment containing Nf1+/-- and c-kit-dependent bone marrow.
    Cell, 2008, Oct-31, Volume: 135, Issue:3

    Topics: Animals; Benzamides; Bone Marrow; Bone Marrow Transplantation; Child, Preschool; Genes, Neurofibromatosis 1; Humans; Imatinib Mesylate; Mast Cells; Mice; Mice, Inbred C57BL; Neurofibroma; Neurofibroma, Plexiform; Neurofibromin 1; Piperazines; Proto-Oncogene Proteins c-kit; Pyrimidines; Schwann Cells

2008
Nf1+/- mast cells induce neurofibroma like phenotypes through secreted TGF-beta signaling.
    Human molecular genetics, 2006, Aug-15, Volume: 15, Issue:16

    Topics: Animals; Benzamides; Bone Marrow Cells; Cell Movement; Cell Proliferation; Collagen; Culture Media, Conditioned; Embryo, Mammalian; Fibroblasts; Fibrosis; Haplotypes; Heterozygote; Humans; Imatinib Mesylate; Mast Cells; Mice; Mice, Inbred C57BL; Mice, Mutant Strains; Neurofibroma; Neurofibromatosis 1; Phenotype; Piperazines; Proto-Oncogene Proteins c-abl; Proto-Oncogene Proteins p21(ras); Pyrimidines; Signal Transduction; Transforming Growth Factor beta

2006